State of Alaska Department of Revenue lessened its holdings in Chemed Co. (NYSE:CHE – Free Report) by 0.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 19,818 shares of the company’s stock after selling 35 shares during the period. State of Alaska Department of Revenue’s holdings in Chemed were worth $10,498,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds have also modified their holdings of the business. EP Wealth Advisors LLC raised its holdings in Chemed by 1.9% in the 3rd quarter. EP Wealth Advisors LLC now owns 1,354 shares of the company’s stock valued at $814,000 after buying an additional 25 shares during the period. Ballentine Partners LLC increased its position in shares of Chemed by 4.1% during the third quarter. Ballentine Partners LLC now owns 655 shares of the company’s stock valued at $394,000 after acquiring an additional 26 shares during the last quarter. Creative Planning raised its stake in shares of Chemed by 2.8% in the 2nd quarter. Creative Planning now owns 1,228 shares of the company’s stock valued at $667,000 after acquiring an additional 34 shares during the period. First Heartland Consultants Inc. lifted its holdings in shares of Chemed by 7.2% in the 3rd quarter. First Heartland Consultants Inc. now owns 508 shares of the company’s stock worth $305,000 after acquiring an additional 34 shares during the last quarter. Finally, First Trust Direct Indexing L.P. boosted its position in shares of Chemed by 4.5% during the 3rd quarter. First Trust Direct Indexing L.P. now owns 887 shares of the company’s stock worth $533,000 after purchasing an additional 38 shares during the period. 95.85% of the stock is currently owned by hedge funds and other institutional investors.
Chemed Stock Performance
Shares of CHE stock opened at $554.31 on Friday. Chemed Co. has a fifty-two week low of $512.12 and a fifty-two week high of $654.62. The company has a 50 day moving average price of $543.62 and a 200 day moving average price of $564.38. The stock has a market capitalization of $8.34 billion, a P/E ratio of 28.01, a price-to-earnings-growth ratio of 2.19 and a beta of 0.48.
Insiders Place Their Bets
Analyst Upgrades and Downgrades
CHE has been the topic of a number of research reports. Royal Bank of Canada decreased their price target on Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a research note on Tuesday, November 5th. StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a report on Saturday, November 30th.
Get Our Latest Stock Report on CHE
Chemed Company Profile
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Featured Articles
- Five stocks we like better than Chemed
- What Are Dividends? Buy the Best Dividend Stocks
- Price Plunge in Roblox Presents Opportunity for Robust Gains
- Where Do I Find 52-Week Highs and Lows?
- Billions in Buybacks: 4 Stocks Rewarding Shareholders Now
- What is a Low P/E Ratio and What Does it Tell Investors?
- 3 Steel Stocks to Gain Strength as Tariffs Reshape the Market
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHE – Free Report).
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.